EP1162886A4 - System and method for evaluating agents which prevent oxidative damage - Google Patents
System and method for evaluating agents which prevent oxidative damageInfo
- Publication number
- EP1162886A4 EP1162886A4 EP00910266A EP00910266A EP1162886A4 EP 1162886 A4 EP1162886 A4 EP 1162886A4 EP 00910266 A EP00910266 A EP 00910266A EP 00910266 A EP00910266 A EP 00910266A EP 1162886 A4 EP1162886 A4 EP 1162886A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- oxidative damage
- prevent oxidative
- evaluating agents
- inhibiting
- identifying agents
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 230000004792 oxidative damage Effects 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 2
- 239000003795 chemical substances by application Substances 0.000 abstract 2
- 210000002950 fibroblast Anatomy 0.000 abstract 2
- 230000002401 inhibitory effect Effects 0.000 abstract 2
- 101000851054 Homo sapiens Elastin Proteins 0.000 abstract 1
- 102000054289 human ELN Human genes 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
- 239000003642 reactive oxygen metabolite Substances 0.000 abstract 1
- 238000011830 transgenic mouse model Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
- A01K67/0275—Genetically modified vertebrates, e.g. transgenic
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
- A01K67/0275—Genetically modified vertebrates, e.g. transgenic
- A01K67/0278—Knock-in vertebrates, e.g. humanised vertebrates
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2207/00—Modified animals
- A01K2207/15—Humanized animals
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/10—Mammal
- A01K2227/105—Murine
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
- A01K2267/0393—Animal model comprising a reporter system for screening tests
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Environmental Sciences (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Toxicology (AREA)
- Animal Behavior & Ethology (AREA)
- Biodiversity & Conservation Biology (AREA)
- Animal Husbandry (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12141899P | 1999-02-23 | 1999-02-23 | |
US121418P | 1999-02-23 | ||
PCT/US2000/004438 WO2000049876A1 (en) | 1999-02-23 | 2000-02-22 | System and method for evaluating agents which prevent oxidative damage |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1162886A1 EP1162886A1 (en) | 2001-12-19 |
EP1162886A4 true EP1162886A4 (en) | 2003-02-12 |
Family
ID=22396604
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP00910266A Withdrawn EP1162886A4 (en) | 1999-02-23 | 2000-02-22 | System and method for evaluating agents which prevent oxidative damage |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1162886A4 (en) |
JP (1) | JP2002541774A (en) |
AU (1) | AU760969B2 (en) |
CA (1) | CA2362904A1 (en) |
WO (1) | WO2000049876A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100406569C (en) * | 2001-02-05 | 2008-07-30 | 潘申权 | Methods and kits for identifing scavengers of reactive oxygen species (Ros) |
US20080312128A1 (en) * | 2005-04-29 | 2008-12-18 | Edward Chaum | Cellular Biomarker Antioxidant Assay and Uses Thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5840734A (en) * | 1997-05-06 | 1998-11-24 | Thomas Jefferson University | Use of tempol in the prevention of photoaging |
WO1999030682A1 (en) * | 1997-12-17 | 1999-06-24 | Color Access, Inc. | Novel antioxidant mixture |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5648061A (en) * | 1995-05-24 | 1997-07-15 | Thomas Jefferson University | In vivo and in vitro model of cutaneous photoaging |
WO1996037237A1 (en) * | 1995-05-24 | 1996-11-28 | Thomas Jefferson University | An in vivo and in vitro model of cutaneous photoaging |
-
2000
- 2000-02-22 WO PCT/US2000/004438 patent/WO2000049876A1/en not_active Application Discontinuation
- 2000-02-22 EP EP00910266A patent/EP1162886A4/en not_active Withdrawn
- 2000-02-22 CA CA002362904A patent/CA2362904A1/en not_active Abandoned
- 2000-02-22 JP JP2000600496A patent/JP2002541774A/en active Pending
- 2000-02-22 AU AU32388/00A patent/AU760969B2/en not_active Ceased
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5840734A (en) * | 1997-05-06 | 1998-11-24 | Thomas Jefferson University | Use of tempol in the prevention of photoaging |
WO1999030682A1 (en) * | 1997-12-17 | 1999-06-24 | Color Access, Inc. | Novel antioxidant mixture |
Non-Patent Citations (3)
Title |
---|
MIYACHI YOSHIKI: "Photoaging from an oxidative standpoint.", JOURNAL OF DERMATOLOGICAL SCIENCE, vol. 9, no. 2, 1995, pages 79 - 86, XP002223927, ISSN: 0923-1811 * |
See also references of WO0049876A1 * |
TAKEUCHI T ET AL: "A NOVEL IN VIVO MODEL FOR EVALUATING AGENTS THAT PROTECT AGAINST ULTRAVIOLET A-INDUCED PHOTOAGING", JOURNAL OF INVESTIGATIVE DERMATOLOGY, NEW YORK, NY, US, vol. 110, April 1998 (1998-04-01), pages 343 - 347, XP000995139, ISSN: 0022-202X * |
Also Published As
Publication number | Publication date |
---|---|
WO2000049876A1 (en) | 2000-08-31 |
JP2002541774A (en) | 2002-12-10 |
EP1162886A1 (en) | 2001-12-19 |
AU3238800A (en) | 2000-09-14 |
AU760969B2 (en) | 2003-05-22 |
CA2362904A1 (en) | 2000-08-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002211304A1 (en) | Systems and methods for assessing vascular effects of a treatment | |
AU1630501A (en) | Compositions and methods for detecting protein modification and enzymatic activity | |
AU6611200A (en) | System and method for delivering agents into targeted tissue of a living being | |
WO2000072480A3 (en) | Light amplification apparatus with automatic monitoring and controls | |
AU6053900A (en) | Compositions for treating or preventing neurodegeneration and cognitive decline | |
AU2209599A (en) | Methods and systems for the inhibition of vascular hyperplasia | |
AU2002236527A1 (en) | Nutrient supplements and methods for treating autism and for preventing the onset of autism | |
AU4302101A (en) | Prognostic testing of organs intended for transplantation | |
EP1219636A3 (en) | Modified muteins of erythropoietin (EPO) derived from in vitro or in vivo expression system of microorganisms | |
AU4535700A (en) | Steel for heat-resistant and/or high-tensile formed parts | |
AU6157899A (en) | Catheter flush solution and method for its use | |
WO1998018440A3 (en) | Use of inhibitors of the activity of retinoic acid for treating sensitive skin | |
AU2731001A (en) | System and method for determining and controlling the impact of text | |
AU5100798A (en) | Genetic markers and methods for the detection of (listeria monocytogenes) and (listeria spp) | |
AU2002246655A1 (en) | Compositions and methods for detecting proteolytic activity | |
EP1162886A4 (en) | System and method for evaluating agents which prevent oxidative damage | |
AU4452400A (en) | Construction and method for undersurface laser marking | |
EP1163514A4 (en) | AN $i(IN VIVO) AND $i(IN VITRO) MODEL FOR CUTANEOUS PHOTOAGING AND OXIDATIVE DAMAGE | |
AU6500600A (en) | Methods and compositions for determining enzymatic activity | |
AU5559300A (en) | Method of making and identifying attenuated microorganisms, compositions utilizing the sequences responsible for attenuation, and preparations containing attenuated microorganisms | |
AU3583000A (en) | Method for direct steelmaking | |
AU2002226980A1 (en) | Sampling and storage system for genetic material from tissue | |
AU2000266752A1 (en) | Plant promoter derived from luminal binding protein gene and methods for its use | |
EP1210595A4 (en) | System for monitoring the expression and/or location of transgenes | |
WO2000012118A8 (en) | Inhibiting cardiomyocyte death |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20010924 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: CHARLES RIVER LABORATORIES |
|
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: CHARLES RIVER LABORATORIES |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: CHARLES RIVER LABORATORIES |
|
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: CHARLES RIVER LABORATORIES |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20030102 |
|
17Q | First examination report despatched |
Effective date: 20040225 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20040706 |